Search research articles
Contact Us
Filters
Showing results (131-140 of 299) with videos related to
Page
of 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2007
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning
Apar Kishor Ganti, Stephanie J Lee, Julie M Vose, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 27, 2017
Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy
Ji Yuan, Timothy C Greiner, Kai Fu, et al.
Cancer Genetics and Cytogenetics
|
January 11, 2007
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion
Avadhut D Joshi, John D Dickinson, Ganapati V Hegde, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
February 9, 2002
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice
Samuel C Augustine, Jeffrey P Norenberg, David M Colcher, et al.
Leukemia Research
|
March 21, 2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease
Maher Albitar, Julie M Vose, Marcella M Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease
Julie M Vose, Graham Sharp, Wing C Chan, et al.
EJNMMI Research
|
January 9, 2014
18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair
Marielle J Wondergem, Ken Herrmann, Sergei Syrbu, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Proteome landscape of B-cell malignancies identifies mantle cell lymphoma protein signature
Samantha A Swenson, C Bea Winship, Kasidy K Dobish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma
Thomas E Witzig, Peter H Wiernik, Timothy Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2013
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial
Julie M Vose, Shelly Carter, Linda J Burns, et al.
Page
of 30
Search research articles
Search
Showing results (131-140 of 299) with videos related to
Sort By:
Page
of 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2007
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning
Apar Kishor Ganti, Stephanie J Lee, Julie M Vose, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 27, 2017
Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy
Ji Yuan, Timothy C Greiner, Kai Fu, et al.
Cancer Genetics and Cytogenetics
|
January 11, 2007
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion
Avadhut D Joshi, John D Dickinson, Ganapati V Hegde, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
February 9, 2002
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice
Samuel C Augustine, Jeffrey P Norenberg, David M Colcher, et al.
Leukemia Research
|
March 21, 2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease
Maher Albitar, Julie M Vose, Marcella M Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease
Julie M Vose, Graham Sharp, Wing C Chan, et al.
EJNMMI Research
|
January 9, 2014
18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair
Marielle J Wondergem, Ken Herrmann, Sergei Syrbu, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Proteome landscape of B-cell malignancies identifies mantle cell lymphoma protein signature
Samantha A Swenson, C Bea Winship, Kasidy K Dobish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma
Thomas E Witzig, Peter H Wiernik, Timothy Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2013
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial
Julie M Vose, Shelly Carter, Linda J Burns, et al.
Page
of 30